TrialInvestigational new drugs2013

Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer.

Keun Seok Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.